Objective: To review evidence-based data with respect to safety and efficacy of alternate-day statin therapy in dyslipidaemia compared to the standard daily dose. Methods: The literature review was conducted at Aga Khan University Hospital, Karachi from July, 2016 to August, 2017. Electronic database search was carried out to compile available literature using PubMed, Excerpta Medica database and Google Scholar. The most relevant evidence-based research articles published over 10 years were selected. The latest search was dated August 03, 2017. Results: A total of 2,074 articles were initially located. Alternate day statin regimen was reported in 53% of articles. Adverse effects on muscle and tendon were reported in 69% of articles. After scrutiny, 19(0.9%) studies covering alternate-day statin-mediated muscle and tendon disorders and 9(0.4%) studies encompassing the potential pathophysiological mechanisms of statin-associated muscle and tendon injury were selected. Except pravastatin and lovastatin, alternate-day statin therapy was almost as effective in lowering total cholesterol, low-density lipoprotein cholesterol and triglyceridesas the daily do sing with low incidence of muscle toxicity and tendinopathy. Conclusion: Alternate-day statin regimen was found to be very well tolerated and might be an effective and safe remedy in clinical practice.
|Number of pages||8|
|Journal||JPMA. The Journal of the Pakistan Medical Association|
|Publication status||Published - Jul 2019|
- Adverse effects
- Alternate-day regimen
- Muscle disorders
- Tendon disorders